(919) 237-4897 info@t3dtherapeutics.com

CHICAGO, AUGUST 25, 2020 — The Clinical trials investigating 16 promising therapies for Alzheimer’s and dementia are taking off thanks to $24 million in new grant funding from the Alzheimer’s Association’s Part the Cloud global research grant program and Bill Gates.

Read Full Press Release Here